EA1131
A Randomized Phase III Post-Operative Trial of Platinum Based Chemotherapy Vs. Capecitabine in Patients with Residual Triple-Negative Breast Cancer following Neoadjuvant Chemotherapy
Trial overview
| Disease | Breast cancer treatment and diagnosis |
| Topic | EA1131 |
| Description | Primary Objective To compare the IDFS in TNBC patients with residual basal-like disease after neoadjuvant chemotherapy who are randomized to postpreoperative platinum-based chemotherapy with those who are randomized to capecitabine |
| Physicians | Dr. Mohammad JahanzebMD, FACP, FASCO Medical Oncologist Works at 3 centers.Dr. Edgardo SantosMD Medical Oncologist Works at 3 centers. |